In addition, TP53 mutations also showed a possible correlation with increased resistance to CI-1040 (p = 0.00882) in cancer cell lines from the Genomics of Drug Sensitivity in Cancer database (Supplementary Table S2) [24]. This evidence concerns the gene TP53 and cancer.